T Nakamura, Y Sato, Y Yamada… - Advanced drug delivery …, 2022 - Elsevier
A new era of nanomedicines that involve nucleic acids/gene therapy has been opened after two decades in 21st century and new types of more efficient drug delivery systems (DDS) …
Mucosa has now been recognized as a potential site for both local and systemic delivery of therapeutics. Mucoadhesive drug delivery systems with customizable release profiles have …
Herein, we report on the development of chitosan-capped silver nanoparticles (AgNPs-CHI) with an intrinsic activity against breast cancer cells. Following chemical synthesis via a …
HM Tawfeek, MA Younis, BN Aldosari… - Drug Development …, 2023 - Taylor & Francis
Objective and significance Silver nanoparticles (AgNPs) have become an interesting therapeutic modality and drug delivery platform. Herein, we aimed to investigate the impact …
Objective Recent developments in nanotechnology have regained hope in enabling the eradication of lung cancer, while overcoming the drawbacks of the classic therapeutics …
Sulpiride (SUL) is a dopamine D2-receptor antagonist used for management of GIT disturbance and it has anti-psychotic activities based on the administered dose. SUL …
Water‐soluble and highly stable N, S‐doped CQDs (N, S‐CQDs) were synthesized using a low‐cost strategy with citric acid and thiosemicarbazide in one step for use as a fluorescent …
D Joshi, NK Choudhary - Journal of Pharmaceutical Innovation, 2024 - Springer
Background Hypertension poses a global health challenge, contributing significantly to mortality and cardiovascular diseases in both developed and low-to middle-income nations …
D Joshi, NK Choudhary - Journal of Pharmaceutical Innovation, 2024 - Springer
Purpose Heart failure, a progressive cardiovascular disorder, significantly affects patient morbidity and mortality. Valsartan, an angiotensin II receptor antagonist, is widely used to …